- Home
- ABEO vs VERI Comparison
ABEO vs VERI Comparison
Compare ABEO & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- VERI
- Stock Information
- Founded
- ABEO 1974
- VERI 2014
- Country
- ABEO United States
- VERI United States
- Employees
- ABEO N/A
- VERI 487
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- VERI EDP Services
- Sector
- ABEO Health Care
- VERI Technology
- Exchange
- ABEO Nasdaq
- VERI Nasdaq
- Market Cap
- ABEO 289.2M
- VERI 588.2M
- IPO Year
- ABEO 1980
- VERI 2017
- Fundamental
- Price
- ABEO $5.49
- VERI $6.69
- Analyst Decision
- ABEO Strong Buy
- VERI Strong Buy
- Analyst Count
- ABEO 6
- VERI 4
- Target Price
- ABEO $18.17
- VERI $9.75
- AVG Volume (30 Days)
- ABEO 1.0M
- VERI 10.0M
- Earning Date
- ABEO 11-13-2025
- VERI 11-06-2025
- Dividend Yield
- ABEO N/A
- VERI N/A
- EPS Growth
- ABEO N/A
- VERI N/A
- EPS
- ABEO 0.99
- VERI N/A
- Revenue
- ABEO $400,000.00
- VERI $90,902,000.00
- Revenue This Year
- ABEO N/A
- VERI $19.12
- Revenue Next Year
- ABEO $324.71
- VERI $17.82
- P/E Ratio
- ABEO $5.69
- VERI N/A
- Revenue Growth
- ABEO N/A
- VERI N/A
- 52 Week Low
- ABEO $3.93
- VERI $1.22
- 52 Week High
- ABEO $7.54
- VERI $9.42
- Technical
- Relative Strength Index (RSI)
- ABEO 44.77
- VERI 61.26
- Support Level
- ABEO $5.21
- VERI $4.77
- Resistance Level
- ABEO $5.73
- VERI $9.42
- Average True Range (ATR)
- ABEO 0.24
- VERI 0.66
- MACD
- ABEO 0.06
- VERI 0.12
- Stochastic Oscillator
- ABEO 55.05
- VERI 43.83
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.